Skip to main content

Table 1 Characteristics of eligible studies in this meta-analysis

From: PODXL might be a new prognostic biomarker in various cancers: a meta-analysis and sequential verification with TCGA datasets

Author

Year

Country

No. of Patient

Tumor type

Method

Cut-off

Outcome

Analysis

Antibody

NOS

Somasiri

2004

Canada

272

Breast cancer

IHC

IHC ≥ 50%

CSS

K-M Curve

M

7

Hsu

2010

Taiwan

303

Renal cell carcinoma

IHC

IHC score ≥ 1

OS, CSS, MFS

Multivariate

P

8

Larsson

2011

Sweden

626

Colorectal cancer

IHC

IHC score ≥ 3

OS, CSS

Multivariate

P

8

Cipollone

2012

Canada

479

Ovarian cancer

IHC

IHC score ≥ 1

DFS

K-M Curve

M

8

Larsson

2012

Sweden

607

Colorectal cancer

IHC

IHC score ≥ 3

OS, DFS, TTR

Multivariate

P

9

Binder

2013

America

181

Glioblastoma multiforme

IHC

NA

OS

Multivariate

NA

7

Boman

2013

Sweden

100

Urothelial bladder cancer

IHC

IHC score ≥ 3

OS

Multivariate

M/P

7

Boman

2013

Sweden

343

Urothelial bladder cancer

IHC

IHC score ≥ 3

OS, CSS, PFS

Multivariate

M/P

8

Forse

2013

Canada

698

Breast cancer

IHC

IHC score ≥ 3

DFS

Multivariate

P

9

Kaprio

2014

Finland

840

Colorectal cancer

IHC

IHC score ≥ 3

CSS

K-M Curve

M/P

9

Heby

2015

Sweden

175

Pancreatic and periampullary adenocarcinoma

IHC

IHC score ≥ 2

OS, DFS

Multivariate

P

7

Laitinen

2015

Finland

337

Gastric cancer

IHC

IHC score ≥ 1

CSS

Multivariate

M/P

8

Saukkonen

2015

Finland

189

Pancreatic ductal adenocarcinoma

IHC

IHC score ≥ 3

CSS

Multivariate

M/P

7

Borg

2016

Sweden

106

Esophageal cancer

IHC

IHC score ≥ 1

OS, TTR

K-M Curve

P

7

Borg

2016

Sweden

65

Gastric cancer

IHC

IHC score ≥ 1

OS, TTR

K-M Curve

p

7

Chijiiwa

2016

Japan

70

Pancreatic cancer

IHC

IHC score ≥ 4

OS, DFS

K-M Curve

M

7

Taniuchi

2016

Japan

102

Pancreatic cancer

IHC

IHC score ≥ 3

OS

Multivariate

P

7

Kusumoto

2017

Japan

114

Lung adenocarcinoma

IHC

IHC score ≥ 1

OS, DFS, CSS

K-M Curve

NA

8

Yuan

2018

China

87

Colorectal cancer

IHC

IHC score ≥ 3

OS

Multivariate

M

7

Zhang

2018

China

54

Gastric cancer

IHC

IHC score ≥ 1

OS, DFS

Multivariate

NA

7

  1. IHC Immunohistochemistry, NA Not Available, OS Overall Survival, DFS Disease-free Survival, CSS Cancer-specific Survival, NOS Newcastle-Ottawa Scale